Pitcairn’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-8,058
| Closed | -$2.27M | – | 30 |
|
|
2025
Q3 | $2.27M | Sell |
8,058
-3,475
| -30% | -$1.01M | 0.18% | 102 |
|
|
2025
Q2 | $3.22M | Sell |
11,533
-2,619
| -19% | -$742K | 0.21% | 85 |
|
|
2025
Q1 | $4.41M | Sell |
14,152
-674
| -5% | -$199K | 0.27% | 68 |
|
|
2024
Q4 | $3.86M | Sell |
14,826
-1,311
| -8% | -$389K | 0.23% | 76 |
|
|
2024
Q3 | $5.2M | Sell |
16,137
-1,488
| -8% | -$487K | 0.31% | 54 |
|
|
2024
Q2 | $5.51M | Buy |
17,625
+1,718
| +11% | +$505K | 0.34% | 48 |
|
|
2024
Q1 | $4.52M | Buy |
15,907
+509
| +3% | +$149K | 0.29% | 59 |
|
|
2023
Q4 | $4.43M | Buy |
15,398
+2,026
| +15% | +$552K | 0.33% | 50 |
|
|
2023
Q3 | $3.59M | Sell |
13,372
-448
| -3% | -$112K | 0.3% | 56 |
|
|
2023
Q2 | $3.07M | Sell |
13,820
-2,987
| -18% | -$693K | 0.26% | 69 |
|
|
2023
Q1 | $4.06M | Sell |
16,807
-666
| -4% | -$163K | 0.37% | 41 |
|
|
2022
Q4 | $4.59M | Buy |
17,473
+709
| +4% | +$190K | 0.46% | 37 |
|
|
2022
Q3 | $3.78M | Sell |
16,764
-1,513
| -8% | -$367K | 0.41% | 38 |
|
|
2022
Q2 | $4.45M | Buy |
18,277
+1,679
| +10% | +$411K | 0.47% | 30 |
|
|
2022
Q1 | $4.01M | Buy |
16,598
+204
| +1% | +$46.9K | 0.35% | 48 |
|
|
2021
Q4 | $3.69M | Buy |
16,394
+3,286
| +25% | +$694K | 0.24% | 63 |
|
|
2021
Q3 | $2.79M | Buy |
13,108
+857
| +7% | +$197K | 0.19% | 74 |
|
|
2021
Q2 | $2.99M | Sell |
12,251
-28
| -0.2% | -$6.89K | 0.2% | 66 |
|
|
2021
Q1 | $3.06M | Sell |
12,279
-1,334
| -10% | -$318K | 0.22% | 67 |
|
|
2020
Q4 | $3.13M | Sell |
13,613
-4,936
| -27% | -$1.14M | 0.24% | 63 |
|
|
2020
Q3 | $4.71M | Sell |
18,549
-2,025
| -10% | -$502K | 0.4% | 37 |
|
|
2020
Q2 | $4.85M | Sell |
20,574
-1,472
| -7% | -$336K | 0.47% | 33 |
|
|
2020
Q1 | $4.47M | Buy |
22,046
+3,111
| +16% | +$680K | 0.53% | 23 |
|
|
2019
Q4 | $4.57M | Buy |
18,935
+4,423
| +30% | +$975K | 0.42% | 32 |
|
|
2019
Q3 | $2.81M | Buy |
14,512
+371
| +3% | +$71.2K | 0.28% | 49 |
|
|
2019
Q2 | $2.61M | Sell |
14,141
-2,585
| -15% | -$463K | 0.26% | 54 |
|
|
2019
Q1 | $3.18M | Buy |
16,726
+2,259
| +16% | +$431K | 0.35% | 40 |
|
|
2018
Q4 | $2.82M | Buy |
14,467
+4,785
| +49% | +$934K | 0.31% | 45 |
|
|
2018
Q3 | $2.01M | Buy |
9,682
+4,150
| +75% | +$818K | 0.21% | 61 |
|
|
2018
Q2 | $1.02M | Sell |
5,532
-134
| -2% | -$23.7K | 0.11% | 118 |
|
|
2018
Q1 | $966K | Sell |
5,666
-1,943
| -26% | -$357K | 0.1% | 125 |
|
|
2017
Q4 | $1.32M | Buy |
7,609
+1,003
| +15% | +$178K | 0.13% | 100 |
|
|
2017
Q3 | $1.23M | Sell |
6,606
-248
| -4% | -$43.9K | 0.14% | 101 |
|
|
2017
Q2 | $1.18M | Sell |
6,854
-3,045
| -31% | -$495K | 0.14% | 100 |
|
|
2017
Q1 | $1.62M | Buy |
9,899
+2,129
| +27% | +$354K | 0.2% | 70 |
|
|
2016
Q4 | $1.14M | Sell |
7,770
-509
| -6% | -$76.6K | 0.14% | 113 |
|
|
2016
Q3 | $1.38M | Buy |
8,279
+250
| +3% | +$42.3K | 0.17% | 90 |
|
|
2016
Q2 | $1.22M | Buy |
8,029
+2,871
| +56% | +$446K | 0.16% | 97 |
|
|
2016
Q1 | $773K | Sell |
5,158
-64
| -1% | -$9.51K | 0.1% | 173 |
|
|
2015
Q4 | $847K | Buy |
5,222
+182
| +4% | +$28.6K | 0.09% | 156 |
|
|
2015
Q3 | $697K | Buy |
5,040
+43
| +0.9% | +$6.78K | 0.09% | 183 |
|
|
2015
Q2 | $767K | Sell |
4,997
-233
| -4% | -$37.3K | 0.09% | 181 |
|
|
2015
Q1 | $836K | Sell |
5,230
-14
| -0.3% | -$2.21K | 0.09% | 180 |
|
|
2014
Q4 | $835K | Sell |
5,244
-16
| -0.3% | -$2.49K | 0.09% | 173 |
|
|
2014
Q3 | $739K | Sell |
5,260
-158
| -3% | -$20.6K | 0.08% | 190 |
|
|
2014
Q2 | $641K | Sell |
5,418
-496
| -8% | -$57.4K | 0.07% | 210 |
|
|
2014
Q1 | $729K | Sell |
5,914
-6,582
| -53% | -$798K | 0.08% | 196 |
|
|
2013
Q4 | $1.43M | Buy |
12,496
+1,057
| +9% | +$120K | 0.16% | 112 |
|
|
2013
Q3 | $1.28M | Buy |
11,439
+544
| +5% | +$59K | 0.16% | 115 |
|
|
2013
Q2 | $1.07M | Buy |
+10,895
| New | +$1.13M | 0.14% | 135 |
|
Other funds holding AMGN
Pitcairn's AMGN Position: Q4 2025 in Review
Pitcairn sold out of Amgen (AMGN) in Q4 2025, closing a stake of 8,058 shares — an estimated $2.27M sold.
Pitcairn first reported a position in AMGN in Q2 2013 and held it in 50 quarters. The position peaked at $5.51M in Q2 2024. 3,084 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.
- Pitcairn reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
- Pitcairn sold 8,058 Amgen shares in Q4 2025, an estimated $2.27M.
- Pitcairn first reported a position in Amgen in Q2 2013 and held it in 50 quarters.
- Pitcairn's Amgen position peaked at $5.51M in Q2 2024.
- 3,084 funds tracked by Wall St. Rank held Amgen as of Q4 2025.
Based on Pitcairn's 13F filing for Q4 2025.